Roche Holding AG (LON:0TDF)

Market Cap	210.56B
Revenue (ttm)	55.00B
Net Income (ttm)	7.30B
Shares Out	n/a
EPS (ttm)	9.09
PE Ratio	28.86
Forward PE	n/a
Dividend	0.66 (1.60%)
Ex-Dividend Date	Mar 14, 2024

Volume	215
Average Volume	43,750
Open	41.29
Previous Close	41.00
Day's Range	41.25 - 41.50
52-Week Range	29.35 - 41.85
Beta	n/a
RSI	68.40
Earnings Date	Jan 31, 2025

About Roche Holding AG

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and New Zealand. The company offers pharma solutions in the therapeutic areas of anaemia, blood and solid tumors, dermatology, haemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation. It also provides in vitro tests for the diagnosis of various diseases, such as cancer, diabetes, Covid-19, hepatitis, human papillomavirus, and others; diagn...

• Industry: Pharmaceutical Preparations
• Founded: 1896
• Employees: 103,249
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0TDF

Financial Performance

In 2024, Roche Holding AG's revenue was 62.40 billion, an increase of 3.23% compared to the previous year's 60.44 billion. Earnings were 8.28 billion, a decrease of -28.01%.

Financial numbers in CHF